We’ve know and have been tracking that cancers are being diagnosed younger and younger for 20+ years now. Now it’s time to start addressing population wide early childhood exposures to carcinogens, diet, obesity and alcohol to start changing this! pressroom.cancer.org/index.php?s=20…

This is going to be such a great discussion on how we can work together to reach patients and combat misinformation! Amy Comander MD, DipABLM Sign up for the COSMO meeting!!

Join us on 8/14 to learn the connection between clinical research and practical treatment applications with a special focus on metastatic breast cancer in our next webinar with Eleonora Teplinsky, MD! Sign up here 👉 bit.ly/drteplinsky #breastcancer #clinicaltrials #digitalhealth

Fun day with theSkimm talking all about clinical trials!

T-5 weeks!! Sign up and join us! It’s going to be 🤗🤗🤗! #cosmo24

News from Industry Out on Business Wire Trastuzumab deruxtecan has received its eighth U.S.🇺🇸Breakthrough Therapy Designation (BTD) for unresectable or metastatic hormone receptor-positive HER2 low or HER2 ultralow #breastcancer businesswire.com/news/home/2024… This designation,

So excited to hear Narjust Florez, MD, FASCO speak on this topic! Are you joining us at the #COSMO24 meeting?! Sign up! All info ⬇️

COSMO Eleonora Teplinsky, MD Darcy Burbage, DNP, RN, AOCN Martina Murphy, MD Stephanie Graff, MD, FACP, FASCO Dr. Emily K. Drake Maryam Lustberg MD, MPH, FASCO Amy Comander MD, DipABLM Shikha Jain MD, FACP Stacey Tinianov (she/her) MPH, BCPA Mark Lewis, MD, FASCO We are excited to join you all! #COSMO24

Less than 4 weeks to go! Two days full of oncology, medicine and social media (and you get CME!) 🔗 cme-learning.brown.edu/COSMO-24 📍Providence, RI -9/18-9/19

May never come back 🇮🇹!

Can’t wait!! Hope to see you there!

Woohooo!!! So excited!!!

💜September is GYN Cancer Awareness Month!💜 Join me & FdtnForWomensCancer Chair Ginger J. Gardner to learn how SGO & FdtnForWomensCancer are teaming up to promote facts📚, symptom recognition👀, & highlighting heroes🦸‍♀️who Multiply Our IMPACT🔥in treating/preventing GYN cancers. #GCAM 1/

Getting so excited for the COSMO meeting!! Make sure you register. Great opportunity for residents and fellows also!! ⬇️ below!

The press needs to stop being a PR machine for celebrity health quests that are now being made public to sell books. Either be a journalist and get the details and report on it responsibly, or pass.

And here’s the OncoAlert check it out list for breast cancer abstracts at #ESMO24!

Come join us in 2 weeks for the COSMO Meeting 2024! Looking forward to networking and learning different ways to use social media effectively in oncology Jasmin Hundal, M.D., M.S., M.P.H. Eleonora Teplinsky, MD Stephanie Graff, MD, FACP, FASCO Amy Comander MD, DipABLM Don S. Dizon MD (he/him) 🇬🇺 Martina Murphy, MD

An excellent read. Looking forward to seeing the #ESMO24 data. Will be interesting to see what happens if there is an FDA approval for adjuvant ribociclib…and especially how we think about it in the node negative population.